Finally, loss of MYBBP1A is observed in a significant percentage of patients with renal cell carcinoma, who show a metastatic tendency and poor prognosis, probably due to the increased stem phenotype caused by c-MYB activation. The gene discussed is MYB; the disease is renal cell carcinoma.